1. Feng, Xiaoteng, Zhang, Yifan, Du, Min, Wang, Yiru, Liu, Ping. 2022. Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease. In Journal of translational medicine, 20, 399. doi:10.1186/s12967-022-03614-1. https://pubmed.ncbi.nlm.nih.gov/36064568/
2. Liao, Jiahe, Yu, Xinbo, Huang, Ziwei, Luo, Jing, Tao, Qingwen. 2024. Chemokines and lymphocyte homing in Sjögren's syndrome. In Frontiers in immunology, 15, 1345381. doi:10.3389/fimmu.2024.1345381. https://pubmed.ncbi.nlm.nih.gov/38736890/
3. Lu, Lin, Du, Huan, Huang, Haowei, Guan, Mingmei, Liu, Guolong. 2020. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells. In International journal of medical sciences, 17, 912-920. doi:10.7150/ijms.40864. https://pubmed.ncbi.nlm.nih.gov/32308544/
4. Jamal, Muhammad, Lei, Yufei, He, Hengjing, Zhou, Fuling, Zhang, Quiping. 2023. CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis. In Frontiers in pharmacology, 14, 1257289. doi:10.3389/fphar.2023.1257289. https://pubmed.ncbi.nlm.nih.gov/37745085/
5. Kadowaki, Atsushi, Saga, Ryoko, Lin, Youwei, Sato, Wakiro, Yamamura, Takashi. . Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis. In Brain : a journal of neurology, 142, 916-931. doi:10.1093/brain/awz012. https://pubmed.ncbi.nlm.nih.gov/30770703/